• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

Estimation of tumor proliferative activity according to expression of cell-cycle-related antigen and selection of fractionation schema in radiation therapy.

Research Project

Project/Area Number 08671025
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

NISHIMURA Yasumasa  Department of Rediology, Kyoto University, Associate Professor, 医学研究科, 助教授 (00218207)

Project Period (FY) 1996 – 1997
Keywordsradiation therapy, / fractionation / proliferative activity / Q cell / cell-cycle-related antigen / immunohistochemical staining / antiangiogenic agent
Research Abstract

We have performed various basic and clinical studies on tumor proliferation and radiation therapy,
1)To understand better the repopulation kinetics of tumor cells after radiotherapy (RT), we investigated changes in cell proliferative parameters after single-dose irradiation of murine tumors. As one of conclusions, recruitment of previously quiescent cells into the proliferative pool in the tumors was suggested to contribute to repopulation after RT.(ref.2)
2)Combined effects of an antiangiogenic agent (TNP-470) with fractionated RT were investigated using a murine tumor. The tumor control probability decreased by administrating TPN-470 during fractionated RT in air. This unexpected result may be contributable to partial inhibition of reoxygenation by TNP-470, because no significant changes in TCD-50 under hypoxic conditions by TNP-470. (ref.6)
3)The effects of overall treatment time (OTT) on local control of RT were evaluated to consider optimal OTT in RT.Local control rates and acute and … More late toxicities of esophageal cancer, glottic cancer, and uterine cervical cancer were analyzed. In the multivariate analysis, OTT was a significant prognostic factor for local control. In conclusion, OTT should be kept as short as Possible wiyhin the limits of tolerance of normal tissues and patients. (ref.4)
4)The relationship of immunohistochemical indices of proliferating cell nuclear antigen (PCNA) and Ki-67 to local control and survival rates for patients with esophageal squamous cell carcinomas treated by definitive radiotherapy (RT) was investigated. Biopsy materials before RT were obtained from 65 patients with esophageal cancer. The PCNA LI was independent of known prognostic factors on local control for esophageal cancer. Patients with the PCNA LI of<50% or the Ki-67 LI of<45% showed significantly higher local recurrence rates than those with higher LIs (p<0.05). In conclusion, PCNA LI and Ki-67 LI were significantly correlated with local control probabilities in esophageal. squamous cell carcinomas treated by definitive RT.PCNA LI may be a useful parameter for selecting the fractionation scheme of esophageal cancers. Less

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Nishimura Y., et al: "Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia." Br.J.Cancer. 73. 270-274 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murata R., Nishimura Y., et al: "Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single dose irradiation" Jpn.J.Cancer Res.87. 662-668 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishimura Y., et al: "Radiation therapy for T1,2 glottic carcinoma : impact of overall treatment time on local control." Radiotherapy and Oncol.40. 225-232 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishimura Y., et al: "Optimal overall treatment time in fractionated radiotherapy for head and neck cancere,esophageal cancer and uterine cervical cancer." J.Jpn.Soc.Ther.Radiol.Oncol.8. 303-315 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Murata R., Nishimura Y., at al: "An anti-Angiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma." Int.J.Radiat.Oncol.Biol.Phys.37. 1107-1113 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masunaga S., Nishimura Y., et al: "Reduction of hypoxic cells in solid tumours induced by mild hyperthermia : special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations." Br.J.Cancer. 76. 588-593 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nishimura Y., Murata R., Hiraoka M: "Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia" Br.J.Cancer. 73. 270-274 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murata R., Nishimura Y., Shibamoto Y., Hiraoka M., Abe M.: "Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single dose irradiation" Jpn.J.Cancer Res.87. 662-668 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishimura Y., Nagata Y., Okajima K., Mitsumori M., Hiraoka M., Masunaga S., Ono K., Shoji K., Kojima H.: "Radiation therapy for T 1,2 glottic carcinoma : impact of overall treatment time on local control." Radiotherapy and Oncol.40. 225-232 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishimura Y., Okajima K., Hiraoka M: "Optimal overall treatment time in fractionated radiotherapy for head and neck cancers, esophageal cancer, and uterine cervical cancer." J.Jpn.Soc.Ther.Radiol.Oncol.8. 303-315 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibamoto Y., Nishimura Y., Tsutsui K., Sasai K., Takahashi M., Abe M.: "Cmparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma." Jpn.J.Clin Oncol. 27. 31-36 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Murata R., Nishimura Y., Hiraoka M: "An anti-angiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma" Int.J.Radiat.Oncol.Biol.Phys.37. 1107-1113 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishimura Y., Shibamoto Y., Hosotani R., Ohshio G., Kokubo M., Kanamori S., Sasai K., Hiraoka M., Imamura M., Abe M.: "IORT for pancreatic cancer ; the Kyoto University experience" Frout.Radiat.Ther.Oncol.Basel Karger. 31. 184-188 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuroda M., Urano M., Nishimura Y.: "Reynolds R. : Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma." Int.J.Radiat.Oncol.Biol.Phys.38. 411-417 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masunaga S., Ono K., Akaboshi M., Nishimura Y., Suzuki M., Kinashi Y., Takagaki M., Hiraoka M., Abe M.: "Reduction of hypoxic cells in solid tumours induced by mild hyperthermia : special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations." Br.J.Cancer. 76. 588-593 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nishimura Y., Hosotani R., Shibamoto Y., Kokubo M., Kanamori S., Sasai K., Hiraoka M., Ohshio G., Imamura M., Takahashi M., Abe M.: "External and intraoperative radiotherapy for resectable and unresectable pancreatric cancer : analysis of survival rates and complications." Int.J.Radiat.Oncol.Biol.Phys.39. 39-49 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shibamoto Y., Ohshio G., Hosotani R., Nishimura Y., Manabe T., Imamura M., Abe M.: "A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy." Br.J.Cancer. 76. 1474-1479 (1997)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi